| histone lysine methylation | GO:0034968 | 50 | 0.593 | Human |
| cell differentiation in hindbrain | GO:0021533 | 24 | 0.579 | |
| stem cell fate specification | GO:0048866 | 3 | 0.558 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.544 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.537 | |
| protein methylation | GO:0006479 | 81 | 0.535 | Human |
| digestive system development | GO:0055123 | 200 | 0.530 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.489 | |
| t cell activation | GO:0042110 | 289 | 0.466 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.466 | Human |
| covalent chromatin modification | GO:0016569 | 163 | 0.452 | Human |
| regulation of mapk cascade | GO:0043408 | 248 | 0.446 | |
| i kappab kinase nf kappab signaling | GO:0007249 | 85 | 0.430 | |
| mapk cascade | GO:0000165 | 281 | 0.426 | |
| dna metabolic process | GO:0006259 | 303 | 0.409 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.405 | |
| gene silencing | GO:0016458 | 38 | 0.387 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.356 | |
| regulation of defense response | GO:0031347 | 233 | 0.329 | |
| digestive tract development | GO:0048565 | 190 | 0.302 | |
| chromatin modification | GO:0016568 | 187 | 0.301 | Human |
| peptidyl lysine modification | GO:0018205 | 77 | 0.279 | Human |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.261 | |
| regulation of feeding behavior | GO:0060259 | 3 | 0.258 | |
| muscle tissue development | GO:0060537 | 308 | 0.256 | |
| amine metabolic process | GO:0009308 | 45 | 0.255 | |
| positive regulation of transcription from rna polymerase ii promoter in response to stress | GO:0036003 | 3 | 0.246 | |
| neural tube closure | GO:0001843 | 90 | 0.240 | |
| gland development | GO:0048732 | 330 | 0.236 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.234 | |
| chromatin organization | GO:0006325 | 206 | 0.229 | Human |
| lymphocyte differentiation | GO:0030098 | 242 | 0.222 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.210 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.210 | |
| skeletal system development | GO:0001501 | 356 | 0.206 | |
| negative regulation of mapk cascade | GO:0043409 | 65 | 0.205 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.203 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.201 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.195 | |
| hepaticobiliary system development | GO:0061008 | 67 | 0.192 | |
| male gamete generation | GO:0048232 | 285 | 0.190 | |
| cerebellar cortex formation | GO:0021697 | 22 | 0.188 | |
| neuroblast fate commitment | GO:0014017 | 1 | 0.188 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.185 | |
| t cell differentiation | GO:0030217 | 174 | 0.179 | |
| endocytosis | GO:0006897 | 168 | 0.170 | |
| protein dna complex subunit organization | GO:0071824 | 28 | 0.166 | |
| positive regulation of ossification | GO:0045778 | 47 | 0.165 | |
| regulation of chromatin silencing | GO:0031935 | 2 | 0.162 | |
| germ cell development | GO:0007281 | 185 | 0.161 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.159 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.157 | |
| macromolecule methylation | GO:0043414 | 120 | 0.155 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.150 | |
| t cell proliferation | GO:0042098 | 120 | 0.147 | |
| histone modification | GO:0016570 | 159 | 0.147 | Human |
| camera type eye development | GO:0043010 | 266 | 0.147 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.147 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.145 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.143 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.140 | |
| axon guidance | GO:0007411 | 141 | 0.140 | |
| chemotaxis | GO:0006935 | 247 | 0.140 | |
| cardiac muscle hypertrophy in response to stress | GO:0014898 | 10 | 0.137 | |
| translation | GO:0006412 | 93 | 0.134 | |
| stem cell differentiation | GO:0048863 | 268 | 0.132 | |
| positive regulation of macroautophagy | GO:0016239 | 3 | 0.130 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.130 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.129 | |
| histone methylation | GO:0016571 | 71 | 0.125 | Human |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.125 | |
| external genitalia morphogenesis | GO:0035261 | 1 | 0.119 | |
| stem cell maintenance | GO:0019827 | 130 | 0.116 | |
| striated muscle adaptation | GO:0014888 | 26 | 0.115 | |
| midgut development | GO:0007494 | 4 | 0.115 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.110 | |
| epithelial cell development | GO:0002064 | 159 | 0.110 | |
| cerebellar purkinje cell layer morphogenesis | GO:0021692 | 14 | 0.108 | |
| respiratory tube development | GO:0030323 | 167 | 0.107 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.107 | |
| chromatin silencing | GO:0006342 | 15 | 0.105 | |
| stress activated protein kinase signaling cascade | GO:0031098 | 81 | 0.101 | |
| oogenesis | GO:0048477 | 56 | 0.101 | |
| cell cycle checkpoint | GO:0000075 | 47 | 0.100 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.100 | |
| placenta development | GO:0001890 | 140 | 0.099 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.098 | |
| regulation of protein localization | GO:0032880 | 231 | 0.097 | |
| motor neuron axon guidance | GO:0008045 | 26 | 0.097 | |
| female gamete generation | GO:0007292 | 74 | 0.096 | |
| negative regulation of chromatin silencing | GO:0031936 | 1 | 0.095 | |
| olfactory learning | GO:0008355 | 2 | 0.093 | |
| positive regulation of histone deacetylation | GO:0031065 | 7 | 0.093 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.091 | |
| metencephalon development | GO:0022037 | 89 | 0.088 | |
| limb morphogenesis | GO:0035108 | 149 | 0.087 | |
| neuron projection guidance | GO:0097485 | 141 | 0.086 | |
| spermatogenesis | GO:0007283 | 284 | 0.086 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.086 | |
| ossification | GO:0001503 | 216 | 0.084 | |
| embryonic viscerocranium morphogenesis | GO:0048703 | 8 | 0.083 | |
| cerebellar purkinje cell layer development | GO:0021680 | 26 | 0.082 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.082 | |
| activation of immune response | GO:0002253 | 138 | 0.077 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.076 | |
| jnk cascade | GO:0007254 | 72 | 0.075 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.074 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.074 | |
| fat cell differentiation | GO:0045444 | 160 | 0.074 | |
| lymphocyte homeostasis | GO:0002260 | 64 | 0.074 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.073 | |
| dna recombination | GO:0006310 | 92 | 0.072 | |
| cerebellar purkinje cell differentiation | GO:0021702 | 13 | 0.072 | |
| type i pneumocyte differentiation | GO:0060509 | 7 | 0.072 | |
| nuclear transcribed mrna catabolic process deadenylation dependent decay | GO:0000288 | 12 | 0.072 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.072 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.071 | |
| dna methylation | GO:0006306 | 43 | 0.071 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.069 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.069 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.069 | |
| clara cell differentiation | GO:0060486 | 4 | 0.068 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.068 | |
| mitotic sister chromatid cohesion | GO:0007064 | 1 | 0.068 | |
| regulation of system process | GO:0044057 | 200 | 0.067 | |
| histone h3 k9 trimethylation | GO:0036124 | 6 | 0.066 | |
| oocyte anterior posterior axis specification | GO:0007314 | 2 | 0.066 | |
| cerebellar cortex development | GO:0021695 | 48 | 0.066 | |
| chromatin mediated maintenance of transcription | GO:0048096 | 2 | 0.066 | |
| learning or memory | GO:0007611 | 148 | 0.066 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.066 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.065 | |
| cerebellum morphogenesis | GO:0021587 | 42 | 0.064 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.064 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.064 | |
| inflammatory response | GO:0006954 | 244 | 0.063 | |
| cerebellar granule cell differentiation | GO:0021707 | 9 | 0.062 | |
| lung development | GO:0030324 | 164 | 0.062 | |
| posttranslational protein targeting to membrane | GO:0006620 | 2 | 0.061 | |
| regulation of adaptive immune response | GO:0002819 | 90 | 0.061 | |
| multicellular organismal reproductive behavior | GO:0033057 | 23 | 0.061 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.061 | |
| peptidyl lysine methylation | GO:0018022 | 29 | 0.061 | Human |
| muscle cell differentiation | GO:0042692 | 261 | 0.061 | |
| ventricular cardiac myofibril assembly | GO:0055005 | 3 | 0.059 | |
| stem cell development | GO:0048864 | 219 | 0.059 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.058 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.058 | |
| autophagy | GO:0006914 | 45 | 0.058 | |
| embryonic hemopoiesis | GO:0035162 | 23 | 0.058 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.058 | |
| regulation of translation | GO:0006417 | 71 | 0.057 | |
| chromatin remodeling | GO:0006338 | 32 | 0.056 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.056 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.055 | |
| embryonic placenta development | GO:0001892 | 98 | 0.055 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.055 | |
| posttranscriptional gene silencing | GO:0016441 | 10 | 0.054 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.053 | |
| protein acylation | GO:0043543 | 64 | 0.053 | |
| regulation of dna templated transcription in response to stress | GO:0043620 | 9 | 0.053 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.053 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.053 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.053 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.052 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.052 | |
| regulation of autophagy | GO:0010506 | 30 | 0.052 | |
| multicellular organism growth | GO:0035264 | 161 | 0.052 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.052 | |
| cd4 positive cd25 positive alpha beta regulatory t cell differentiation | GO:0002361 | 4 | 0.051 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 82 | 0.051 | |
| regulation of postsynaptic membrane potential | GO:0060078 | 48 | 0.051 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.051 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.051 | |
| ribonucleoprotein complex subunit organization | GO:0071826 | 28 | 0.051 | |
| muscle hypertrophy | GO:0014896 | 24 | 0.051 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.050 | |
| gonad development | GO:0008406 | 141 | 0.050 | |
| gene silencing by mirna | GO:0035195 | 10 | 0.049 | |
| regulation of innate immune response | GO:0045088 | 91 | 0.049 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.048 | Human |
| regulation of jnk cascade | GO:0046328 | 62 | 0.048 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.048 | |
| hindbrain morphogenesis | GO:0021575 | 46 | 0.048 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.048 | |
| acute inflammatory response | GO:0002526 | 41 | 0.048 | |
| dna damage checkpoint | GO:0000077 | 26 | 0.047 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.047 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.047 | |
| histone h4 acetylation | GO:0043967 | 10 | 0.047 | |
| respiratory system development | GO:0060541 | 190 | 0.046 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.045 | |
| blood circulation | GO:0008015 | 195 | 0.045 | |
| mrna metabolic process | GO:0016071 | 84 | 0.045 | |
| heart contraction | GO:0060047 | 93 | 0.045 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.045 | |
| regulation of protein deacetylation | GO:0090311 | 17 | 0.045 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.044 | |
| protein processing | GO:0016485 | 163 | 0.044 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.044 | |
| regulation of cell migration | GO:0030334 | 219 | 0.044 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.044 | |
| regulation of stress activated mapk cascade | GO:0032872 | 69 | 0.044 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.044 | |
| regulation of lymphocyte mediated immunity | GO:0002706 | 84 | 0.043 | |
| sister chromatid segregation | GO:0000819 | 20 | 0.043 | |
| organ growth | GO:0035265 | 117 | 0.042 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.041 | |
| regulation of heart contraction | GO:0008016 | 77 | 0.041 | |
| heart morphogenesis | GO:0003007 | 178 | 0.041 | |
| megakaryocyte differentiation | GO:0030219 | 26 | 0.041 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.041 | |
| dna integrity checkpoint | GO:0031570 | 28 | 0.041 | |
| regulation of cell activation | GO:0050865 | 289 | 0.040 | |
| negative regulation of mitotic cell cycle | GO:0045930 | 58 | 0.040 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.040 | |
| rna splicing via transesterification reactions | GO:0000375 | 43 | 0.040 | |
| body morphogenesis | GO:0010171 | 45 | 0.040 | |
| uterus morphogenesis | GO:0061038 | 2 | 0.040 | |
| regulation of protein processing | GO:0070613 | 96 | 0.039 | |
| negative regulation of response to wounding | GO:1903035 | 77 | 0.039 | |
| liver development | GO:0001889 | 66 | 0.039 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.039 | Human |
| nuclear division | GO:0000280 | 158 | 0.039 | |
| kidney development | GO:0001822 | 213 | 0.039 | |
| cardiac muscle hypertrophy | GO:0003300 | 23 | 0.039 | |
| synaptic transmission | GO:0007268 | 329 | 0.039 | |
| peptidyl lysine acetylation | GO:0018394 | 45 | 0.039 | |
| regulation of nuclear transcribed mrna poly a tail shortening | GO:0060211 | 4 | 0.039 | |
| chromatin assembly | GO:0031497 | 13 | 0.039 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.038 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.038 | |
| regulation of acute inflammatory response | GO:0002673 | 27 | 0.038 | |
| negative regulation of inflammatory response | GO:0050728 | 61 | 0.038 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.038 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.038 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.037 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.037 | |
| reproductive behavior | GO:0019098 | 32 | 0.037 | |
| positive regulation of stress activated mapk cascade | GO:0032874 | 48 | 0.037 | |
| positive regulation of chromosome organization | GO:2001252 | 33 | 0.037 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.037 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.036 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.036 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.036 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.036 | |
| cellular response to starvation | GO:0009267 | 57 | 0.036 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.036 | |
| lung cell differentiation | GO:0060479 | 30 | 0.036 | |
| regulation of organ growth | GO:0046620 | 61 | 0.036 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.036 | |
| heart process | GO:0003015 | 94 | 0.035 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.035 | |
| methylation | GO:0032259 | 134 | 0.035 | |
| hindbrain development | GO:0030902 | 128 | 0.035 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.035 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.035 | |
| regulation of n methyl d aspartate selective glutamate receptor activity | GO:2000310 | 10 | 0.035 | |
| lung epithelial cell differentiation | GO:0060487 | 29 | 0.035 | |
| gene silencing by rna | GO:0031047 | 19 | 0.034 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.034 | |
| regulation of mrna processing | GO:0050684 | 41 | 0.034 | |
| somite development | GO:0061053 | 81 | 0.033 | |
| regulation of gene silencing | GO:0060968 | 7 | 0.033 | |
| rna splicing via transesterification reactions with bulged adenosine as nucleophile | GO:0000377 | 43 | 0.033 | |
| positive regulation of leukocyte proliferation | GO:0070665 | 73 | 0.033 | |
| neural tube development | GO:0021915 | 160 | 0.033 | |
| organelle assembly | GO:0070925 | 177 | 0.033 | |
| regulation of transcription from rna polymerase ii promoter in response to stress | GO:0043618 | 8 | 0.033 | |
| mesenchyme development | GO:0060485 | 152 | 0.033 | |
| cognition | GO:0050890 | 149 | 0.032 | |
| lung ciliated cell differentiation | GO:0061141 | 1 | 0.032 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.032 | |
| pole plasm assembly | GO:0007315 | 2 | 0.032 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.032 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.032 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.032 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.031 | |
| phagocytosis | GO:0006909 | 66 | 0.031 | |
| skin morphogenesis | GO:0043589 | 38 | 0.031 | |
| intracellular receptor signaling pathway | GO:0030522 | 74 | 0.031 | Human |
| muscle adaptation | GO:0043500 | 39 | 0.031 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.031 | |
| cerebellar granular layer development | GO:0021681 | 13 | 0.031 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.031 | |
| somitogenesis | GO:0001756 | 69 | 0.031 | |
| regulation of protein transport | GO:0051223 | 163 | 0.030 | |
| labyrinthine layer development | GO:0060711 | 49 | 0.030 | |
| male sex differentiation | GO:0046661 | 109 | 0.030 | |
| activation of mapk activity | GO:0000187 | 59 | 0.030 | |
| cell proliferation involved in heart valve development | GO:2000793 | 2 | 0.029 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.029 | |
| regulation of rna splicing | GO:0043484 | 37 | 0.029 | |
| genitalia development | GO:0048806 | 37 | 0.029 | |
| appendage development | GO:0048736 | 166 | 0.029 | |
| negative regulation of adaptive immune response | GO:0002820 | 25 | 0.029 | |
| forebrain development | GO:0030900 | 302 | 0.029 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.029 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.028 | |
| phosphatidylinositol mediated signaling | GO:0048015 | 41 | 0.028 | |
| positive regulation of map kinase activity | GO:0043406 | 84 | 0.028 | |
| lung epithelium development | GO:0060428 | 37 | 0.028 | |
| negative regulation of defense response | GO:0031348 | 77 | 0.028 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.028 | |
| membrane depolarization | GO:0051899 | 64 | 0.028 | |
| negative regulation of mesenchymal cell proliferation | GO:0072201 | 3 | 0.028 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.028 | |
| neuroblast differentiation | GO:0014016 | 2 | 0.028 | |
| central nervous system neuron development | GO:0021954 | 67 | 0.028 | |
| innate immune response | GO:0045087 | 157 | 0.028 | |
| pteridine containing compound metabolic process | GO:0042558 | 5 | 0.027 | |
| macroautophagy | GO:0016236 | 21 | 0.027 | |
| central nervous system neuron axonogenesis | GO:0021955 | 28 | 0.027 | |
| histone h3 k9 methylation | GO:0051567 | 17 | 0.027 | |
| exocytosis | GO:0006887 | 121 | 0.027 | |
| regulation of anterior head development | GO:2000742 | 2 | 0.027 | |
| positive regulation of fat cell differentiation | GO:0045600 | 32 | 0.027 | |
| regulation of pancreatic juice secretion | GO:0090186 | 4 | 0.027 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.027 | |
| segmentation | GO:0035282 | 93 | 0.027 | |
| response to alcohol | GO:0097305 | 48 | 0.027 | |
| erythrocyte maturation | GO:0043249 | 6 | 0.026 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.026 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.026 | |
| negative regulation of growth | GO:0045926 | 99 | 0.026 | |
| immune response activating signal transduction | GO:0002757 | 116 | 0.026 | |
| rhombomere morphogenesis | GO:0021593 | 2 | 0.026 | |
| alpha beta t cell differentiation | GO:0046632 | 69 | 0.026 | |
| dendrite development | GO:0016358 | 115 | 0.026 | |
| regulation of fear response | GO:1903365 | 2 | 0.026 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.025 | |
| epidermis morphogenesis | GO:0048730 | 33 | 0.025 | |
| oxidation reduction process | GO:0055114 | 342 | 0.025 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.025 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.025 | |
| multi organism reproductive behavior | GO:0044705 | 29 | 0.025 | |
| positive regulation of growth | GO:0045927 | 104 | 0.025 | |
| regulation of t cell proliferation | GO:0042129 | 92 | 0.025 | |
| protein alkylation | GO:0008213 | 81 | 0.025 | Human |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.025 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.025 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.025 | |
| maintenance of chromatin silencing | GO:0006344 | 2 | 0.025 | |
| cell fate commitment | GO:0045165 | 210 | 0.025 | |
| male meiosis | GO:0007140 | 37 | 0.025 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.025 | |
| cerebellum development | GO:0021549 | 77 | 0.024 | |
| regulation of ossification | GO:0030278 | 112 | 0.024 | |
| negative regulation of t cell proliferation | GO:0042130 | 38 | 0.024 | |
| striated muscle hypertrophy | GO:0014897 | 24 | 0.024 | |
| natural killer cell activation | GO:0030101 | 44 | 0.024 | |
| t cell differentiation in thymus | GO:0033077 | 77 | 0.024 | |
| oocyte construction | GO:0007308 | 2 | 0.024 | |
| regulation of meiotic cell cycle | GO:0051445 | 34 | 0.024 | |
| response to inorganic substance | GO:0010035 | 96 | 0.024 | |
| regulation of leukocyte mediated immunity | GO:0002703 | 104 | 0.024 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.024 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.023 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.023 | |
| cerebellar cortex morphogenesis | GO:0021696 | 32 | 0.023 | |
| principal sensory nucleus of trigeminal nerve development | GO:0021740 | 2 | 0.023 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.023 | |
| regulation of cell motility | GO:2000145 | 236 | 0.023 | |
| chromatin remodeling at centromere | GO:0031055 | 2 | 0.023 | |
| glomerulus development | GO:0032835 | 40 | 0.023 | |
| cell adhesion | GO:0007155 | 329 | 0.023 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.023 | |
| regulation of mrna stability | GO:0043488 | 23 | 0.023 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.023 | |
| epithalamus development | GO:0021538 | 2 | 0.023 | |
| regulation of histone deacetylation | GO:0031063 | 12 | 0.023 | |
| definitive hemopoiesis | GO:0060216 | 20 | 0.023 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.022 | |
| habenula development | GO:0021986 | 2 | 0.022 | |
| positive regulation of cell proliferation involved in heart valve morphogenesis | GO:0003251 | 1 | 0.022 | |
| feeding behavior | GO:0007631 | 62 | 0.022 | |
| tube formation | GO:0035148 | 140 | 0.022 | |
| syncytium formation by plasma membrane fusion | GO:0000768 | 42 | 0.022 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.022 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.022 | |
| cellular response to lipid | GO:0071396 | 145 | 0.022 | Human |
| chondrocyte differentiation | GO:0002062 | 72 | 0.022 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.021 | |
| hemangioblast cell differentiation | GO:0060217 | 1 | 0.021 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.021 | |
| blastocyst development | GO:0001824 | 80 | 0.021 | |
| regulation of excitatory postsynaptic membrane potential | GO:0060079 | 41 | 0.021 | |
| negative regulation of translation | GO:0017148 | 22 | 0.021 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.021 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.021 | |
| somatic diversification of immunoglobulins | GO:0016445 | 43 | 0.021 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.021 | |
| regulation of mesenchymal cell proliferation involved in lung development | GO:2000790 | 2 | 0.021 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.021 | |
| natural killer cell differentiation | GO:0001779 | 21 | 0.020 | |
| meiosis i | GO:0007127 | 60 | 0.020 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.020 | |
| spermatid development | GO:0007286 | 108 | 0.020 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.020 | |
| multi organism behavior | GO:0051705 | 62 | 0.020 | |
| ear development | GO:0043583 | 200 | 0.020 | |
| compound eye development | GO:0048749 | 1 | 0.020 | |
| positive regulation of jnk cascade | GO:0046330 | 46 | 0.020 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.020 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.020 | |
| lipid storage | GO:0019915 | 36 | 0.019 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.019 | |
| regulation of histone modification | GO:0031056 | 56 | 0.019 | |
| glucose homeostasis | GO:0042593 | 128 | 0.019 | |
| monoamine transport | GO:0015844 | 33 | 0.019 | |
| response to nutrient levels | GO:0031667 | 109 | 0.019 | |
| inorganic anion transport | GO:0015698 | 43 | 0.019 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.019 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.019 | |
| negative regulation of fat cell differentiation | GO:0045599 | 36 | 0.019 | |
| negative regulation of gene silencing | GO:0060969 | 2 | 0.019 | |
| negative regulation of cell cycle phase transition | GO:1901988 | 48 | 0.019 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.019 | |
| regulation of secretion | GO:0051046 | 274 | 0.019 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.018 | |
| positive regulation of dna templated transcription elongation | GO:0032786 | 2 | 0.018 | |
| lipid localization | GO:0010876 | 126 | 0.018 | |
| response to peptide | GO:1901652 | 136 | 0.018 | |
| mesoderm development | GO:0007498 | 100 | 0.018 | |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 58 | 0.018 | |
| organelle fission | GO:0048285 | 170 | 0.018 | |
| histone h4 deacetylation | GO:0070933 | 4 | 0.018 | |
| establishment or maintenance of microtubule cytoskeleton polarity | GO:0030951 | 1 | 0.018 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.018 | |
| positive regulation of binding | GO:0051099 | 49 | 0.018 | |
| regulation of ion transport | GO:0043269 | 215 | 0.018 | |
| rna interference | GO:0016246 | 2 | 0.018 | |
| positive regulation of histone h3 k9 methylation | GO:0051574 | 4 | 0.018 | |
| negative regulation of cell cycle process | GO:0010948 | 69 | 0.018 | |
| somatic diversification of immune receptors | GO:0002200 | 53 | 0.018 | |
| regulation of embryonic development | GO:0045995 | 71 | 0.018 | |
| regulation of gene expression by genetic imprinting | GO:0006349 | 15 | 0.018 | |
| posttranscriptional gene silencing by rna | GO:0035194 | 10 | 0.018 | |
| epidermis development | GO:0008544 | 187 | 0.018 | |
| circadian regulation of gene expression | GO:0032922 | 48 | 0.017 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.017 | |
| sensory perception of sound | GO:0007605 | 97 | 0.017 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.017 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.017 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.017 | |
| negative regulation of protein catabolic process | GO:0042177 | 36 | 0.017 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.017 | |
| intracellular mrna localization | GO:0008298 | 4 | 0.017 | |
| sensory perception | GO:0007600 | 245 | 0.017 | |
| syncytium formation | GO:0006949 | 43 | 0.017 | |
| regulation of erk1 and erk2 cascade | GO:0070372 | 71 | 0.017 | |
| regulation of bmp signaling pathway | GO:0030510 | 60 | 0.017 | |
| interleukin 6 production | GO:0032635 | 58 | 0.017 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.017 | |
| negative regulation of lymphocyte mediated immunity | GO:0002707 | 21 | 0.017 | |
| negative regulation of lymphocyte proliferation | GO:0050672 | 45 | 0.017 | |
| positive regulation of cell substrate adhesion | GO:0010811 | 47 | 0.017 | |
| protein maturation | GO:0051604 | 176 | 0.017 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.017 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.017 | |
| wound healing | GO:0042060 | 157 | 0.017 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.017 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.017 | |
| developmental maturation | GO:0021700 | 193 | 0.017 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.017 | |
| regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002822 | 87 | 0.017 | |
| histone acetylation | GO:0016573 | 41 | 0.016 | |
| monosaccharide transport | GO:0015749 | 58 | 0.016 | |
| regionalization | GO:0003002 | 337 | 0.016 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.016 | |
| protein deacylation | GO:0035601 | 36 | 0.016 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.016 | |
| face development | GO:0060324 | 38 | 0.016 | |
| regulation of hepatocyte proliferation | GO:2000345 | 6 | 0.016 | |
| muscle system process | GO:0003012 | 141 | 0.016 | |
| germ line stem cell division | GO:0042078 | 2 | 0.016 | |
| protein deacetylation | GO:0006476 | 32 | 0.016 | |
| regulation of terminal button organization | GO:2000331 | 1 | 0.016 | |
| mesoderm formation | GO:0001707 | 62 | 0.016 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.016 | |
| cell differentiation involved in kidney development | GO:0061005 | 33 | 0.016 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.015 | |
| cytokine production | GO:0001816 | 319 | 0.015 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.015 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.015 | |
| primary neural tube formation | GO:0014020 | 95 | 0.015 | |
| muscle fiber development | GO:0048747 | 76 | 0.015 | |
| immune response regulating signaling pathway | GO:0002764 | 125 | 0.015 | |
| peptidyl lysine trimethylation | GO:0018023 | 12 | 0.015 | |
| molting cycle | GO:0042303 | 90 | 0.015 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.015 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.015 | |
| negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090101 | 61 | 0.015 | |
| b cell homeostasis | GO:0001782 | 34 | 0.015 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.015 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.015 | |
| leukocyte homeostasis | GO:0001776 | 79 | 0.015 | |
